Form 8-K - Current report:
SEC Accession No. 0001628280-19-010778
Filing Date
2019-08-14
Accepted
2019-08-14 17:16:00
Documents
3
Period of Report
2019-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2019q28k-earningsrelease.htm 8-K 37546
2 EXHIBIT 99.1 a2019q2-ex991earningsrelea.htm EX-99.1 353283
3 cumberlandpharmaimageaa06.jpg GRAPHIC 37721
  Complete submission text file 0001628280-19-010778.txt   444005
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 191027588
SIC: 2834 Pharmaceutical Preparations